Drug Type Autologous CAR-T |
Synonyms AntiCD19/BCMA bispecific CAR T cell therapy, AntiCD19/BCMA CART cells |
Target |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crouzon Syndrome With Acanthosis Nigricans | Phase 1 | CN | 27 Feb 2019 | |
POEMS Syndrome | Phase 1 | CN | 27 Feb 2019 |